We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCTI.L Regulatory News (CTI)

  • There is currently no data for CTI

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

25 Jul 2019 11:34

RNS Number : 7376G
Cathay International Holdings Ld
25 July 2019
 

 25 July 2019

Dissemination of a Regulatory Announcement that contains inside information according to REGULATION (EU) No 596/2014 (MAR).

Cathay International Holdings Limited

("Cathay", the "Company" or the "Group")

Trading update

Hong Kong, 25 July 2019 - Cathay International Holdings Limited (LSE: CTI.L), an operator and investor in the growing healthcare sector in the People's Republic of China (the "PRC"), provides a trading update for the six months ended 30 June 2019.

The Company expects a lower Group sales and profits in the first half 2019 than the same period last year.

As Lansen announced today in Hong Kong, Lansen expects to have noticeable decrease in its net profits for H1 2019 as compared with the net profit for H1 2018 due to the following reasons:

1. As stated in our 2018 annual report, Lansen has implemented a number of new strategic initiatives in its pharmaceutical business, in response to the challenging regulatory environment in China, by developing its own products such as Pafulin, Sicorten Plus, and certain featured pharmaceuticals; and reducing reliance on agency products. As a result, in the first half of the current financial year, Lansen's sales are below the same period last year.

2. A number of provisions and write-offs have been made against old and slow moving inventory.

3. As at 21 June 2019, Lansen decided not to exercise the put option (the "Put Option") to require Natural Dailyhealth to buy back its holding of 30% equity interest in Natural Dailyhealth. As a result, it has written off the related put option value.

Despite the short term impact on Lansen's results from the new strategic initiatives, Lansen sees improvement in its pharmaceutical segment and expects this segment's profit to be higher than that in same period last year, and looks forward to continuing improvement in the second half.

At Haizi, trading has been adversely impacted by a decrease in the market price for inositol and its results are expected to be below 2018.

Natural Dailyhealth and Botai are both trading broadly in line with expectations.

Our hotel remains profitable, although occupancy and average room rates are below last year and profits will be lower for the first half.

 

The Company's results for six months ended 30 June 2019 will be released in late August.

 

 

For further enquiries, please contact:

 

Cathay International Holdings Limited

Eric Siu (Finance Director)

Patrick Sung (Director and Controller)

 

 

Tel: +852 2828 9289

Consilium Strategic Communications

Mary-Jane Elliott / Matthew Neal / Lindsey Neville

 

 

Tel: +44 (0) 203 709 5702

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTCKPDNKBKDDOB
Date   Source Headline
30th Aug 201911:33 amRNSInterim Results
27th Aug 20194:10 pmRNSLansen reports interim results ended 30 June 2019
16th Aug 201911:46 amRNSNotice of Interim Results
1st Aug 20199:52 amRNSBlock listing Interim Review
25th Jul 201911:34 amRNSTrading Update
12th Jul 20199:24 amRNSChange of Registered Office Address in Bermuda
8th Jul 201912:32 pmRNSUpdate on cross guarantee agreement
28th Jun 20197:00 amRNSTotal Voting Rights
21st Jun 201911:56 amRNSUpdate re Natural Dailyhealth
21st Jun 201910:58 amRNSStatement relating to UK FCA enforcement action
20th Jun 201912:01 pmRNSUpdate on renewal of Cross Guarantee Agreement
12th Jun 201912:02 pmRNSChange of Company Secretary
12th Jun 201911:59 amRNSUpdate on renewal of Cross Guarantee Agreement
11th Jun 201911:41 amRNSDisposal of Starry Shares
10th Jun 20194:08 pmRNSResult of AGM
31st May 201910:51 amRNSStatement relating to UK FCA enforcement action
14th May 201911:54 amRNSDisposal of Starry Shares
3rd May 20192:24 pmRNSRenewal of Cross Guarantee
24th Apr 201912:23 pmRNSStarry Share Disposal
12th Apr 20199:42 amRNSResult of Special General Meeting
29th Mar 201912:49 pmRNSAnnual Results For the Year Ended 31 December 2018
27th Mar 20194:59 pmRNSProposed Further Disposal of Starry Shares
27th Mar 20198:01 amRNSLansen reports annual results
15th Mar 20197:00 amRNSNotice of Annual Results 2018
22nd Feb 20199:32 amRNSBlock listing Interim Review - Replacement
20th Feb 20193:24 pmRNSLansen's fourth share reduction plan of Starry
1st Feb 201910:52 amRNSBlock listing Interim Review
1st Feb 201910:45 amRNSTotal Voting Rights
25th Jan 20199:59 amRNSLansen's release of its Trading Update
31st Dec 20187:00 amRNSInvestment by Lansen in Robustnique
18th Dec 20188:02 amRNSTrading Update
30th Nov 20189:34 amRNSProposed Starry Shares Disposal by Lansen
12th Oct 201810:31 amRNSChange Of Director
20th Sep 20189:43 amRNSHolding(s) in Company
31st Aug 20189:47 amRNSInterim Results
28th Aug 20182:28 pmRNSLansen reports interim results
17th Aug 20187:00 amRNSNotice of Interim Results 2018
13th Jul 20189:11 amRNSTrading Update
4th Jul 20189:05 amRNSSecond Price Monitoring Extn
4th Jul 20189:00 amRNSPrice Monitoring Extension
25th Jun 20188:00 amRNSExtension of put option in Natural Dailyhealth
6th Jun 20181:25 pmRNSLansen's partial disposal of shares in Starry
5th Jun 20189:22 amRNSResults of Annual General Meeting
2nd May 201811:20 amRNSLansen subsidiary enters distribution agreement
16th Apr 201812:43 pmRNSLansen's shareholder loan to Natural Dailyhealth
9th Apr 201811:33 amRNSAnnual Results for the Year Ended 31 December 2018
3rd Apr 201810:14 amRNSLansen's third share reduction plan of Starry
27th Mar 20189:59 amRNS2017 Lansen Annual Results
15th Mar 20187:00 amRNSNotice of Results
9th Feb 20187:43 amRNSLansen appoints Executive Director & Group CEO

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.